ArticleDrug delivery2018

Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.

Ming-Xing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.